PD

DRUG2 trials

Sponsors

KU Leuven, National University Hospital, Singapore

Conditions

AchalasiaRelapse Multiple Myeloma

Phase 3

Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma

National University Hospital, SingaporeRelapse Multiple Myeloma

Start: 2017-09-13End: 2022-06-01Target: 120Updated: 2017-11-06

Unknown Phase

POEM Trial: Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM)

CompletedNCT01793922

KU LeuvenAchalasia

Start: 2013-10-01End: 2022-02-18Updated: 2026-03-23

Related Papers

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003).

2025-10-06

Phase 3 Study of Pomalidomide with Cyclophosphamide and Dexamethasone Versus Pomalidomide and Dexamethasone in Asian Patients with Relapsed/Refractory Myeloma (RRMM) - Interim Analysis of a Trial By the Asian Myeloma Network (AMN)

Blood2020-11-041 citations